Curaleaf Holdings (CURLF) Enterprise Value (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Enterprise Value of -$17.6 million in Q4 2025, down 170.7% quarter-over-quarter from $25.0 million in Q4 2024, and down 170.7% on a YoY basis from $25.0 million in Q4 2024.
Curaleaf Holdings (CURLF) Enterprise Value (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Enterprise Value history runs 7 years deep, the most recent figure standing at -$17.6 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 170.7% year-over-year to -$17.6 million; the TTM figure through Dec 2025 stood at -$17.6 million (down 170.7% YoY), while the FY2025 annual figure was -$17.6 million, down 170.7% from the prior year.
- Enterprise Value was -$17.6 million for Q4 2025 at Curaleaf Holdings, down from $25.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $116.5 billion in Q1 2022 to a low of -$357.6 million in Q3 2022.
- Historically, Enterprise Value has averaged $8.2 billion across 5 years, with a median of $13.1 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Enterprise Value tumbled 649.91% in 2021, then soared 36832.4% in 2022.
- A 5-year view of Enterprise Value shows it stood at $119.0 million in 2021, then tumbled by 400.55% to -$357.6 million in 2022, then soared by 108.06% to $28.8 million in 2023, then fell by 13.45% to $25.0 million in 2024, then plunged by 170.7% to -$17.6 million in 2025.
- The last three Enterprise Value figures came in at -$17.6 million (Q4 2025), $25.0 million (Q4 2024), and $36.1 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.64 Mn |
| Dec 31, 2024 | 24.95 Mn |
| Sep 30, 2024 | 36.13 Mn |
| Jun 30, 2024 | 25.15 Mn |
| Dec 31, 2023 | 28.83 Mn |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 38.28 Mn |
| Sep 30, 2022 | -357.57 Mn |
| Jun 30, 2022 | -343.66 Mn |
| Mar 31, 2022 | 116.55 Bn |
| Dec 31, 2021 | 118.97 Mn |
| Sep 30, 2021 | -186.23 Mn |
| Jun 30, 2021 | -202.61 Mn |
| Mar 31, 2021 | -317.29 Mn |
| Dec 31, 2020 | -76.24 Mn |
| Sep 30, 2020 | -45.00 Mn |
| Jun 30, 2020 | -42.31 Mn |
| Mar 31, 2020 | -42.31 Mn |
| Dec 31, 2019 | -45.00 Mn |
| Sep 30, 2019 | -266.62 Mn |